Showing 1 - 10 of 714
The isolation of national telecommunications markets in the past has meant that pronounced differences remain among the R&D systems operating in the countries of the European Community. The intended opening up of public procurement markets by the end of 1992 could therefore lead to substantial...
Persistent link: https://www.econbiz.de/10011546778
Persistent link: https://www.econbiz.de/10001105664
economies are fuelling calls to contain the so-called evergreening practices of drug producers around the world. But such … exclusivity for pharmaceuticals products and evaluates safeguards against such evergreening. …
Persistent link: https://www.econbiz.de/10011311672
Persistent link: https://www.econbiz.de/10003309695
Attempts by the developing countries to replace the largely voluntary provision of development aid by a system that would free official resource flows from the possibility of political interference by the donors and from the need for yearly budgetary allocations have been going on for some time....
Persistent link: https://www.econbiz.de/10011554344
Persistent link: https://www.econbiz.de/10001432432
Persistent link: https://www.econbiz.de/10003931919
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
Persistent link: https://www.econbiz.de/10003761054
This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their political economy context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...
Persistent link: https://www.econbiz.de/10012803399